Suchergebnisse - "Goodrick, Hannah"

PubPharm (4)

1

Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis

enthalten in: Journal of clinical gastroenterology | 2023

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

2

Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Gupta, S. | Goodrick, H. | +2

3

P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis

enthalten in: The American journal of gastroenterology | 2021

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

4

Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis : A Propensity Score Analysis

enthalten in: Inflammatory bowel diseases | 2021

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

1
[1]